CN Stock MarketDetailed Quotes

300318 Beijing Bohui Innovation Biotechnology Group

Watchlist
  • 5.76
  • +0.17+3.04%
Market Closed Oct 18 15:00 CST
4.71BMarket Cap-1440000P/E (TTM)

About Beijing Bohui Innovation Biotechnology Group Company

The company was founded in 2001 and is a high-tech enterprise focusing on R&D, production, sales and after-sales service of laboratory testing products. Mainly engaged in R&D, production and sales of in vitro diagnostic products. The main products are human trace element detection systems and human papillomavirus (HPV) detection systems, etc.

Company Profile

Short Name-A博晖创新
Symbol-A300318
Company NameBeijing Bohui Innovation Biotechnology Group Co.,Ltd.
Listing DateMay 23, 2012
Issue Price15.00
Shares Offered25.60M share(s)
FoundedJul 12, 2001
Legal Representativezhiwei shen
General Managerzhiwei shen
Secretaryhaifeng dong
Accounting FirmDahua Certified Public Accountants (Special General Partnership)
Securities Representativexuejiao zhang
Legal CounselBeijing Guofeng Law Firm
Employees274
Phone010-88850168
Office AddressNo. 9 Shengshengyuan Road, Changping District, Beijing
Zip Code102206
Registered AddressNo. 9 Shengshengyuan Road, Changping District, Beijing
Fax010-80764188
Emaildsh@bohui-tech.com
Business License110000002965579
BusinessTechnological development of medical devices and medical analytical instruments; sales of self-produced products, medical devices, instrumentation, analytical instruments, electronic equipment; maintenance of instruments; investment management; import and export of goods; import and export; technology import and export; instrument technical training; equipment leasing; leasing of office space and commercial space; production of Class I medical devices; production of Class I medical devices; production of Class II and Class III medical devices; production of experimental analytical instruments. (Enterprises independently select business projects and carry out business activities in accordance with law; produce Class II and Class III medical devices and projects subject to approval according to law, carry out business activities in accordance with the approved content after approval by the relevant departments; they are not allowed to engage in business activities for projects prohibited or restricted by the city's industrial policy.)

Company Executives

  • Name
  • Position
  • Salary
  • zhiwei shen
  • Chairman, Directors, General Manager, Chairman of the Strategy Committee, Nomination Committee Members
  • 1.60M
  • chenglin ceng
  • Directors, Audit Committee Member, Member of the Strategy Committee
  • 1.40M
  • yong shen
  • Directors, Member of the Strategy Committee
  • --
  • haifeng dong
  • Directors, Board Secretary, Deputy General Manager, Member of the Strategy Committee, Member of the Remuneration and Assessment Committee
  • 834.70K
  • jun yin
  • Independent Directors, Chairman of the Remuneration and Assessment Committee, Member of the Strategy Committee, Nomination Committee Members
  • 50.40K
  • xiaosu zhang
  • Independent Directors, Audit Committee Member, Chairman of the Nomination Committee
  • 100.00K
  • jun ban
  • Independent Directors, Chairman of the Audit Committee, Member of the Remuneration and Assessment Committee
  • 100.00K
  • xuejiao zhang
  • Securities Affairs Representative
  • --
  • jianghong du
  • Chairman of the Supervisory Board, Auditors
  • --
  • hengfei xu
  • Auditors
  • 345.30K
  • jia liu
  • Chief Financial Officer
  • 536.00K
  • lanlan hu
  • Employee Supervisors
  • 285.20K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data